Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 211, Issue 1, Pages 137-151Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20131019
Keywords
-
Categories
Funding
- National Institutes of Health [AI057555, AI064639, GM84459, AI104519]
- Sister Institution Network Fund
- seed fund from the Center for Inflammation and Cancer
Ask authors/readers for more resources
Regulatory T cells (T-reg cells) control different aspects of immune responses, but how the effector functions of T-reg cells are regulated is incompletely understood. Here we identified TNF receptor-associated factor 3 (TRAF3) as a regulator of T-reg cell function. T-reg cell-specific ablation of TRAF3 impaired CD4 T cell homeostasis, characterized by an increase in the Th1 type of effector/memory T cells. Moreover, the ablation of TRAF3 in T-reg cells resulted in increased antigen-stimulated activation of follicular T helper cells (T-FH cells), coupled with heightened formation of germinal centers and production of high-affinity IgG antibodies. Although the loss of TRAF3 did not reduce the overall frequency of T-reg cells, it attenuated the antigen-stimulated production of follicular T-reg cells (T-FR cells). TRAF3 signaling in T-reg cells was required to maintain high level expression of inducible co-stimulator (ICOS), which in turn was required for T-FR cell generation and inhibition of antibody responses. These findings establish TRAF3 as a mediator of T-reg cell function in the regulation of antibody responses and suggest a role for TRAF3 in mediating ICOS expression in T-reg cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available